Search results
Early gestational diabetes treatment shown to reduce birth complications, health costs for those at...
Medical Xpress· 2 days agoPublished in eClinicalMedicine, the new study explored whether treatment of gestational diabetes before 20 weeks' gestation among patients at a higher risk is cost ...
The more Americans who take Ozempic, the faster the US economy could grow, Goldman Sachs says
Business Insider via Yahoo Finance· 6 days agoHatzius said health-related problems keep people from participating in the labor force and inhibit ...
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
Morningstar· 3 hours agoHigh obesity drug demand and a scarcity of supply have driven its stock above its intrinsic value.
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Repeated Reimbursement Haircuts From CMS Won’t Bend The Cost Curve
Forbes· 17 hours agoOn average, we spend about twice as much per person on health than other large wealthy countries....
Dickens, Diabetes, and Positive-Sum Games
Acton Commentary· 11 hours agoBad news is always unwelcome and can be terrifying, especially when it affects the health and well-being of someone you love. But we live in a world of...
Study finds Arkansas loses $1.8 billion from poor maternal healthcare
KNWA Fayetteville via Yahoo News· 1 day agoThis resulted in higher medical cost, more time traveling, transportation and lodging costs. This...
Deceptive insurance practices that block medical treatment access need reform
Louisiana Illuminator via Yahoo News· 13 hours agoChronic illnesses continue to burden communities across Louisiana, and patients living with these...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 11 hours agoPalatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system ...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 11 hours agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...